A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.
Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.
Likely to be launched at the annual Worldwide Developers Conference next year, Apple is training the AI-powered health assistant to offer personalised health tracking and insights for users
GCCs in life sciences and healthcare have grown across India, with Bengaluru, Hyderabad, and Chennai emerging as key hubs
A section of ASHA workers, protesting outside the Secretariat here for 39 days, on Thursday intensified their agitation with three of their members starting an indefinite hunger strike as part of their demands for post retirement benefits and increased honorarium. The indefinite hunger strike was kicked off amidst slogans against the ruling Left government with the protesting Accredited Social Health Activist (ASHA) workers accusing it of "corruption" and being "cruel" towards them. Prior to the start of the hunger strike, Congress leader and former state Health Minister V M Sudheeran met the protesting ASHA workers and extended his support to them. Thereafter, speaking to reporters here, he accused the ruling CPI(M) of adopting a "neo-fascist" stand against the protestors. "They appear to be attracted by neo-fascism," he said. When reporters told him that state Health Minister Veena George went to Delhi earlier in the day to raise the issue of the ASHA workers, he termed it as ...
Prudential Group Holdings Ltd, UK Subsidiary of Prudential Plc will own 70 per cent stake in the venture while Vama will hold the remaining 30 per cent
Biosimilars can not only reduce patients' financial burdens, but also encourage more people to go for early diagnosis and comprehensive treatment
Volumes need to be high to justify relocation of manufacturing; strategic decisions cannot be based on current tariff structure
The company's management remains confident that the new hospital will become a strong engine of growth in Cayman over the next few years.
According to reports, UBS said that Max Healthcare is well-positioned for earnings growth, with solid foundations in place
Bajaj's move coincides with growth in Indian health care as the nation's wealth and insurance coverage increases and the number of people reaching retirement age accelerates
The Finance Ministry, in consultation with the Labour Department, is working out the modalities of a scheme to provide healthcare facilities under the PM Jan Arogya Yojana (PM-JAY) to about 1 crore gig workers, Expenditure Secretary Manoj Govil has said. Finance Minister Nirmala Sitharaman, in her Budget speech, announced that the government will arrange identity cards and registration of gig workers on the e-Shram portal. They will be provided healthcare under PM Jan Arogya Yojana. In an interview to PTI, Govil said the parameters and details of the scheme are being worked out in consultation with the Ministry of Labour and concerned other ministries. Govil said the social security scheme for gig workers could either be a 100 per cent Central Sector scheme or a centrally sponsored scheme where the cost would be shared between the Centre and states in a 60:40 ratio. "Once the scheme details are finalised, the cost will be calculated," Govil added. Ayushman Bharat PM-JAY is the la
Union Budget 2025: In the coming year, 10,000 additional medical seats will be created, with a target of adding 75,000 seats over the next five years
The management believes, that on account of ramp-up of existing products, Fermion contract, and potential commercialisation of another CDMO contract in FY26E, Ami has strong revenue visibility.
Arvind Kejriwal highlighted the pivotal role of the middle class in driving the Indian economy, lamenting their exploitation for tax purposes without adequate support
Realisation growth for Dr Lal PathLabs and Vijaya Diagnostic Centre is projected to remain flat compared to the previous year
The Indian pharmaceutical industry is aiming to more than double its size to USD 120-130 billion by 2030 as it looks to ride on the back of innovation to become the healthcare custodian of the world, Indian Pharmaceutical Alliance (IPA) president and Torrent Group chairman Samir Mehta said. In the last 25 years, the Indian pharma industry has grown nearly 20 times - a market size of USD 58 billion from USD 3 billion in 1999-2000, contributing equally to domestic sales and exports today. The sector is among the top five contributors to India's trade surplus, which has grown to USD 19.5 billion from merely USD 1 billion in 1999-2000. "The journey of Indian pharma is a testament to how key policy reforms coupled with entrepreneurial spirit have nurtured the sector's growth," Mehta wrote in an article on the occasion of IPA completing 25 years. "The Indian pharmaceutical sector stands at a critical juncture as India heads toward 2047. From job creation to global trade and innovation to .
Apollo Hospitals, Vijaya Diagnostic and Narayana Hrudayalaya have given a fresh breakout on the daily scale. Charts show that these 5 healthcare related shares can rally up to 11 per cent.
At present, Puri serves on the boards of industry-leading organisations, including Tata Sons, Hindustan Unilever, and Dr. Reddy's Laboratories, further demonstrating his extensive expertise
Healthcare industry body NATHEALTH has asked the government to address systemic gaps such as acute shortage of medical specialists, escalating cancer care costs, and inadequate hospital infrastructure to meet the demands of a growing population in the upcoming union Budget. In its pre-Budget recommendations, NATHEALTH sought increasing budgetary allocations of the healthcare sector to over 2.5 per cent of GDP and asked Finance Minister Nirmala Sitharaman to address the growing burden of communicable and non-communicable diseases, compounded by long standing challenges. "The upcoming Union Budget offers an unprecedented chance to address systemic gaps such as the acute shortage of medical specialists, escalating cancer care costs, and inadequate hospital infrastructure to meet the demands of a growing population," NATHEALTH President Abhay Soi said in a statement. Soi, who is also the Chairman & Managing Director of Max Healthcare Institute Ltd, further said, "Expanding hospital ...